MedPath

Evaluation of an Internet-based Intervention for Hazardous Drinkers

Phase 2
Completed
Conditions
Hazardous Alcohol Consumption
Registration Number
NCT01075685
Lead Sponsor
Institut national de prevention et d'education pour la sante
Brief Summary

The purpose of this study is to determine whether the investigators internet-based intervention is effective to help hazardous drinkers reducing their alcohol consumption.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1157
Inclusion Criteria
  • Alcohol Use Disorders Identification Test (AUDIT) score from 6 (female) or 7 (male) to 12
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Weekly Alcohol Intakebaseline and 6 weeks

The unit of "standard drink" is a drink containing 10g of pure alcohol. Participants had to report their weekly alcohol intake in a diary, in which they could choose among 21 glasses of various capacities and containing various alcoholic drinks. Each of those glasses was then converted into standard drinks.

Secondary Outcome Measures
NameTimeMethod
Relative Change in Weekly Alcohol Intakebaseline and 6 weeks

(6 weeks minus baseline)/baseline

Category of Change in Weekly Alcohol Intakebaseline and 6 weeks

Category of change in weekly alcohol intake (WAI) is a 3-level categorical variable whose values are:

* clinically significant reduction in WAI, defined as a decrease of 10% or over;

* clinically significant increase in WAI, defined as an increase of 10% or over if WAI at baseline is positive, or any increase if WAI at baseline is 0);

* and no clinically significant change, which includes all other cases.

Change in the Number of Excessive Drinkersbaseline and 6 weeks

The number of excessive drinkers is the number of participants whose weekly alcohol intake exceeds guidelines, i.e. 21 or 14 standard drinks (male/female) per week

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.